Arbutus Biopharma Corp Preferred Stock, Accretion of Redemption Discount
Arbutus Biopharma Corp (ABUS) reported Preferred Stock, Accretion of Redemption Discount of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-02.
Discontinued › Shareholders' Equity
us-gaap:PreferredStockAccretionOfRedemptionDiscount · last filed 2023-03-02
- Arbutus Biopharma Corp preferred stock, accretion of redemption discount for the quarter ending 2021-09-30 was $0.00.
- Arbutus Biopharma Corp preferred stock, accretion of redemption discount for the quarter ending 2021-06-30 was $0.00.
- Arbutus Biopharma Corp preferred stock, accretion of redemption discount for the quarter ending 2021-03-31 was $0.00.
- Arbutus Biopharma Corp preferred stock, accretion of redemption discount for the quarter ending 2020-09-30 was $0.00.
- Arbutus Biopharma Corp preferred stock, accretion of redemption discount for fiscal 2021 was $0.00.
- Arbutus Biopharma Corp preferred stock, accretion of redemption discount for fiscal 2020 was $0.00.
- Arbutus Biopharma Corp preferred stock, accretion of redemption discount for fiscal 2019 was $0.00.
- Arbutus Biopharma Corp preferred stock, accretion of redemption discount for fiscal 2018 was $0.00.
| Period end | Preferred Stock, Accretion of Redemption Discount 3 month | Preferred Stock, Accretion of Redemption Discount 6 month | Preferred Stock, Accretion of Redemption Discount 9 month | Preferred Stock, Accretion of Redemption Discount 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2023-03-02 | |||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $0.00 derived: sum of 3 quarters · filed 2022-11-09 | |
| 2021-06-30 | $0.00 10-Q · filed 2021-11-04 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-11-09 | |||
| 2020-12-31 | $0.00 10-K · filed 2022-03-03 | |||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-04 | $0.00 derived: sum of 2 quarters · filed 2021-11-04 | $0.00 derived: sum of 3 quarters · filed 2021-11-04 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-11-04 | $0.00 derived: sum of 2 quarters · filed 2021-11-04 | ||
| 2020-03-31 | $0.00 10-Q · filed 2021-11-04 | |||
| 2019-12-31 | $0.00 10-K · filed 2021-03-04 | |||
| 2019-09-30 | $0.00 10-Q · filed 2020-11-05 | $0.00 derived: sum of 2 quarters · filed 2020-11-05 | $0.00 derived: sum of 3 quarters · filed 2020-11-05 | |
| 2019-06-30 | $0.00 10-Q · filed 2020-11-05 | $0.00 derived: sum of 2 quarters · filed 2020-11-05 | ||
| 2019-03-31 | $0.00 10-Q · filed 2020-11-05 | |||
| 2018-12-31 | $0.00 10-K · filed 2020-03-05 | |||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-06 | $0.00 derived: sum of 2 quarters · filed 2019-11-06 | $0.00 derived: sum of 3 quarters · filed 2019-11-06 | |
| 2018-06-30 | $0.00 10-Q · filed 2019-11-06 | $0.00 derived: sum of 2 quarters · filed 2019-11-06 | ||
| 2018-03-31 | $0.00 10-Q · filed 2019-11-06 | |||
| 2017-12-31 | $0.00 10-K · filed 2019-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |